Jan 31, 2023
Kevin Davies, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about the history of genome technology and its potential to change precision medicine. The first FDA approval for a...
Jan 26, 2023
As myeloproliferative neoplasms are a group of progressive blood cancers that can develop quickly into more serious hematological diseases, hear what community practices need to know about treating these patients quickly and the impact that timeliness of care can have on patient outcomes. In this episode, CANCERBUZZ...
Jan 24, 2023
The patient navigation world has a new kid on the block. Just when we thought we knew everything there was to know about navigators, the role has been reinvented by a concept so intuitive, it is difficult to believe that these navigators are not standard practice in oncology. Meet population health...
Jan 17, 2023
Because most cases of SCLC are diagnosed at advanced stages, it is rarely curable by the time of diagnosis. However, for some patients, treatment can improve quality of life. Multidisciplinary care coordination is especially important with aggressive cases of SCLC, as there may be several unique challenges to be...
Jan 10, 2023
Treatment for patients with CLL has undergone a dramatic transformation with the approval of oral oncolytics. Oral oncolytic treatment for CLL offers many benefits such as convenience and effectiveness. However, with the introduction of oral oncolytic treatments, cancer care teams face new challenges (e.g., medication...